Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;50(8):3000605221115151.
doi: 10.1177/03000605221115151.

Analysis of postoperative radiotherapy for non-metastatic head and neck adenoid cystic carcinoma based on SEER data

Yan Du  1 , Yong Zeng  1
Affiliations

Analysis of postoperative radiotherapy for non-metastatic head and neck adenoid cystic carcinoma based on SEER data

Yan Du et al. J Int Med Res. 2022 Aug.

Abstract

Objective: The postoperative role of adjuvant radiotherapy in non-metastatic head and neck adenoid cystic carcinoma (ACC) remains controversial. We analyzed adjuvant radiotherapy's effect on surgical patient survival.

Methods: Patients diagnosed with ACC from 2004 to 2015 in the Surveillance, Epidemiology, and End Results database were analyzed. The overall survival (OS) and disease-specific survival (DSS) of patients after adjuvant radiotherapy were assessed using the Kaplan-Meier and multivariate Cox methods. Propensity score matching (PSM) was performed to adjust confounders between patients with or without adjuvant radiotherapy; a forest plot was generated by subgroup analysis.

Results: The study included 742 patients. In the PSM cohort, adjuvant radiotherapy did not improve OS or DSS. Radiotherapy was not a protective factor for OS or DSS in the univariate and multivariate Cox proportional hazard models. In the subgroup analysis, postoperative radiotherapy improved the OS of female and N1-stage patients and those with oropharyngeal tumors or over 79 years and the DSS of N1-stage patients.

Conclusions: Postoperative radiotherapy showed different benefits in ACC patients, and postoperative radiotherapy recommendations should be individualized. Female and N1-stage ACC patients and those with oropharyngeal tumors or patients over 79 years without distant metastases postoperatively could benefit from adjuvant radiotherapy.

Keywords: Adenoid cystic carcinoma; SEER database; adjuvant therapy; head and neck carcinoma; postoperative radiotherapy; propensity score matching.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interest: The authors declare that they have no competing interests.

Figures

Figure 1.
Figure 1.
Kaplan–Meier survival curves of overall survival comparing surgery alone to surgery plus adjuvant radiotherapy for resected adenoid cystic carcinoma (ACC) before and after propensity score matching (PSM) (a, c) and Kaplan–Meier survival curves of disease-specific survival comparing surgery alone to surgery plus adjuvant radiotherapy for resected ACC before and after PSM (b, d). RT, radiotherapy; HR, hazard ratio.
Figure 2.
Figure 2.
Forest plot of multivariate analysis of overall survival of resected adenoid cystic carcinoma with or without radiotherapy. The Cox regression model was adjusted for all other prognostic factors listed. The circles denote the hazard ratio of each subgroup. HR, hazard ratio; CI, confidence interval; MSG, minor salivary gland; AJCC, American Joint Committee on Cancer.
Figure 3.
Figure 3.
Forest plot of multivariate analysis for disease-specific survival of resected adenoid cystic carcinoma with or without radiotherapy. The Cox regression model was adjusted for all other prognostic factors listed. The circles denote the hazard ratio of each subgroup. HR, hazard ratio; CI, confidence interval; MSG, minor salivary gland; AJCC, American Joint Committee on Cancer.
See this image and copyright information in PMC

References

    1. Coca-Pelaz A, Rodrigo JP, Bradley PJ, et al.. Adenoid cystic carcinoma of the head and neck – An update. Oral Oncol 2015; 51: 652–661. - PubMed
    1. Laurie SA, Ho AL, Fury MG, et al. Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: A systematic review. Lancet Oncol 2011; 12: 815–824. - PubMed
    1. Amit M, Binenbaum Y, Trejo-Leider L, et al.. International collaborative validation of intraneural invasion as a prognostic marker in adenoid cystic carcinoma of the head and neck. Head Neck 2015; 37: 1038–1045. - PubMed
    1. Liu X, Yang X, Zhan C, et al.. Perineural invasion in adenoid cystic carcinoma of the salivary glands: Where we are and where we need to go. Front Oncol 2020; 10: 1493. - PMC - PubMed
    1. Kowalski PJ, Paulino AF. Perineural invasion in adenoid cystic carcinoma: Its causation/promotion by brain-derived neurotrophic factor. Hum Pathol 2002; 33: 933–936. - PubMed

LinkOut - more resources